CytomX Therapeutics Correlations

CTMX Stock

USD 0.87 0.02 2.25%

The current 90-days correlation between CytomX Therapeutics and ZyVersa Therapeutics is 0.09 (i.e., Significant diversification). The correlation of CytomX Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

CytomX Therapeutics Correlation With Market

Modest diversification

The correlation between CytomX Therapeutics and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CytomX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For more information on how to buy CytomX Stock please use our How to Invest in CytomX Therapeutics guide.

Moving together with CytomX Stock

0.78	XFOR	X4 Pharmaceuticals	Pair Corr
0.74	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.88	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.81	PFE	Pfizer Inc Fiscal Year End 4th of February 2025	Pair Corr
0.85	INZY	Inozyme Pharma	Pair Corr
0.82	KURA	Kura Oncology	Pair Corr
0.77	PALI	Palisade Bio	Pair Corr
0.65	BDRX	Biodexa Pharmaceticals Upward Rally	Pair Corr
0.78	TERN	Terns Pharmaceuticals	Pair Corr
0.81	PPERY	Bank Mandiri Persero	Pair Corr
0.74	PPERF	Bank Mandiri Persero	Pair Corr

Moving against CytomX Stock

0.79	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.7	EWTX	Edgewise Therapeutics	Pair Corr
0.69	PRAX	Praxis Precision Med	Pair Corr
0.67	AKRO	Akero Therapeutics	Pair Corr
0.58	ALVO	Alvotech	Pair Corr
0.54	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.34	VRDN	Viridian Therapeutics	Pair Corr
0.86	CVX	Chevron Corp Fiscal Year End 7th of February 2025	Pair Corr
0.84	BAC	Bank of America Aggressive Push	Pair Corr
0.83	DIS	Walt Disney Aggressive Push	Pair Corr
0.79	JPM	JPMorgan Chase Fiscal Year End 10th of January 2025	Pair Corr
0.78	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.78	WMT	Walmart Aggressive Push	Pair Corr
0.7	SSNLF	Samsung Electronics	Pair Corr
0.68	PTAIF	PT Astra International	Pair Corr

Related Correlations Analysis

	ZVSA	SONN	ZURA	PHIO	RNAZ	QNRX
ZVSA		0.68	-0.08	0.34	-0.19	-0.05	ZVSA
SONN	0.68		0.03	0.55	-0.22	-0.02	SONN
ZURA	-0.08	0.03		0.25	0.54	0.29	ZURA
PHIO	0.34	0.55	0.25		0.14	-0.14	PHIO
RNAZ	-0.19	-0.22	0.54	0.14		-0.03	RNAZ
QNRX	-0.05	-0.02	0.29	-0.14	-0.03		QNRX
	ZVSA	SONN	ZURA	PHIO	RNAZ	QNRX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SONN	+ 0.68	ZVSA
PHIO	+ 0.55	SONN
RNAZ	+ 0.54	ZURA
PHIO	+ 0.34	ZVSA
QNRX	+ 0.29	ZURA
PHIO	+ 0.25	ZURA

High negative correlations

RNAZ	- 0.22	SONN
RNAZ	- 0.19	ZVSA
QNRX	- 0.14	PHIO
ZURA	- 0.08	ZVSA
QNRX	- 0.05	ZVSA
QNRX	- 0.03	RNAZ

Risk-Adjusted Indicators

There is a big difference between CytomX Stock performing well and CytomX Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CytomX Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ZVSA	4.67	(0.99)	0.00	0.60	0.00	0.00	9.17	(10.36)	78.93
SONN	4.76	(0.77)	0.00	2.19	0.00	0.00	12.31	(9.79)	37.58
ZURA	3.78	(0.36)	0.00	(0.09)	0.00	0.00	7.95	(7.94)	30.69
PHIO	4.53	(0.30)	0.00	(0.18)	0.00	0.00	11.78	(10.38)	36.22
RNAZ	7.63	1.05	0.10	(0.44)	6.52	(11.84)	22.00	(11.43)	68.80
QNRX	6.21	0.47	0.07	0.37	6.73	(8.82)	17.65	(9.68)	74.46

CytomX Therapeutics Corporate Management

JD Rowland	General VP	Profile
MBA BS	Head VP	Profile
Danielle OlanderMoghadassian	Senior Officer	Profile
YuWaye MD	Senior Officer	Profile
Christopher Ogden	Principal Accounting	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC